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a b s t r a c t
Using genetic immunisation of mice, we produced antibodies against chicken interleukin-
12p40 (chIL-12p40), also known as IL-12. After a ﬁnal injection with a recombinant
chIL-12p40 protein, several stable hybridoma cell lines were established which secreted
monoclonal antibodies (mAbs) to this component of the heterodimeric IL-12 cytokine. Spe-
ciﬁc binding of three of the mAbs to COS-7 cell-derived recombinant chIL-12p40 and the
chIL-12p70 heterodimer was demonstrated in an indirect ELISA, and in dot blots. Two of
the mAbs were used to develop a capture ELISA, suitable for detecting both recombinant
protein (chIL-12p40 and the heterodimeric p70 protein) andnative chIL-12. ThemAbswere
further characterised to show utility in immunocytochemistry.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
Interleukin-12 (IL-12) is a 70kDa heterodimeric
cytokine, comprising IL-12p35 (IL-12) and IL-12p40 (IL-
12), which plays a crucial role in the initiation and
progressionof aTh1-type response (reviewedbyTrinchieri,
2003). In infections caused by bacteria and intracellu-
lar parasites, IL-12 is produced by antigen-presenting
cells within a few hours of infection. It acts as a pro-
inﬂammatory cytokine, activating NK cells (Chan et al.,
1991) and inducing IFN- production, which in turn
enhances phagocytic and bactericidal activity of phago-
cytic cells and their ability to release IL-12 and other
pro-inﬂammatory cytokines. Furthermore, IL-12 produced
during the early stages of infection or inﬂammation deter-
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mines the ensuing antigen-speciﬁc immune response,
favouring differentiation of CD4+ T cells into Th1 cells,
whilst inhibiting differentiation of Th2 cells through the
resulting production of IFN-.
Until relatively recently, progress in understanding
and dissecting the avian immune response to a variety
of pathogens has been hampered by the lack of cross-
reactivity and low level of sequence homology between
avian and mammalian immune-related molecules. How-
ever, the availability of the chicken genome (International
Chicken Genome Sequencing Consortium, 2004) has pro-
vided aunique resource to further our understanding of the
general biology and more speciﬁcally the immune-related
genes in the chicken (Kaiser et al., 2005). We are now
able to measure expression of many genes, including most
cytokines, at the mRNA level by real-time quantitative RT-
PCR (qRT-PCR) (Eldaghayes et al., 2006; Kaiser and Stäheli,
2008); however, to date, there still remains a paucity
of reagents available to measure the immune response
in the chicken, particularly at the protein level. Indeed,
although the two sub-units of the functional chicken IL-
12p70 molecule were cloned some years ago (Balu and
Kaiser, 2003; Degen et al., 2004), the only assays available
to measure chicken IL-12 (chIL-12) at the protein level are
0165-2427/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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an indirect bioassay based on the stimulation of IFN- syn-
thesis or a non-speciﬁc assay measuring the proliferation
of splenocytes (Degen et al., 2004).
The aim of this study was to generate monoclonal anti-
bodies (mAbs) to chIL-12 for use in assays to speciﬁcally
measure IL-12 production. Using a pair of the anti-chIL-
12 mAbs generated, a capture ELISA was developed that
could detect natural and recombinant chIL-12. The mAbs
also show utility in immunocytochemistry.
2. Materials and methods
2.1. IL-12 expression
A NotI fragment containing the chIL-12p40 cDNA (Balu
and Kaiser, 2003) was inserted into the NotI site in the
polylinker of the eukaryotic expression vector pCI-neo
(Promega, Southampton, UK) giving rise to pCI-neo-chIL-
12p40.
ChFlexi-IL-12, a single-chain chIL-12p35-p40 het-
erodimeric construct cloned into pcDNA3.1 (Invitrogen,
Paisley, Scotland) was a kind gift from W.G.J. Degen, Inter-
vet International BV, Boxmeer, The Netherlands (Degen
et al., 2004).
Both constructs were expressed in COS-7 cells (ex-COS)
using a well-described DEAE-dextran transfection method
(Lawson et al., 2000, 2001; Rothwell et al., 2004; Tregaskes
and Young, 1997).
2.2. Monoclonal antibody production, puriﬁcation and
labelling
MAbs were generated following intramuscular genetic
immunisation of mice with pCI-neo-chIL-12p40 (100g
endotoxin-freeDNA/mouse in a total volume of 100l PBS,
50g/hind quadricep), following a previously described
procedure (Rothwell et al., 2001). Following the fusion,
hybridoma supernatants were screened for antibodies to
chIL-12p40 by indirect ELISA, described below. Positive
hybridomaswere selected for cloning (by limiting dilution)
and expansion. The isotype of each mAb was determined
using the IsoStrip mouse mAb isotyping kit (Roche Diag-
nostics, Burgess Hill, UK), according to the manufacturer’s
instructions.
MAbswere puriﬁed usingHiTrap ProteinG columns (GE
Healthcare Life Sciences, Little Chalfont, UK) according to
themanufacturer’s instructions. Concentrations of puriﬁed
mAbs were determined by absorbance at 280nm, and then
dialysed extensively against PBS using 10,000Da molecu-
lar weight cut-off (MWCO) Slide-A-Lyser cassettes (Perbio
Science, Tattenhall, UK).
Puriﬁed mAbs were conjugated to biotin by incubating
with ImmunoPure Sulfo-NHS-LC-Biotin (Perbio Science)
for 2h at room temperature (RT), as per the manufac-
turer’s instructions. BiotinylatedmAbswere again dialysed
against PBS using 10,000Da MWCO Slide-A-Lyser cas-
settes.
2.3. Antibody assays
Indirect ELISA was performed as described previously
(Rothwell et al., 2001). Brieﬂy, supernatant from fusion
wells (100l) or 50l of mouse serum diluted 1:200 in
PBS containing 0.05% Tween 20 (PBS-T) was added to the
wells of assay plates previously coated with recombinant
chIL-12p40 (rchIL-12p40) ex-COS. Speciﬁcally-bound anti-
body was detected with a secondary biotinylated goat
anti-mouse IgG (GE Healthcare Life Sciences), followed
by streptavidin–horseradish peroxidase (AbD Serotec,
Kidlington, UK). Peroxidase activity was revealed with
o-phenylenediamine (OPD) substrate (Sigma, Poole, UK),
and absorbance was read at 492nm in a SpectraMax 250
microplate spectrophotometer system (Molecular Devices,
Sunnyvale, CA, USA).
A capture ELISA was developed using the anti-chIL-
12p40 mAbs described in this paper. Falcon Microtest III
ﬂexible assay plates (Becton–Dickinson, Oxnard, CA, USA)
were coated by overnight incubation at 4 ◦C with capture
mAbs (1–5g/ml in PBS, 50l/well). Plates were washed
three times with PBS-T, and then blocked with 100l/well
PBS-T containing 1% BSA (Sigma) for 2h. After a further
three washes in PBS-T, 50l/well recombinant or native
IL-12-enriched culture supernatant were added, and incu-
bated for 2h at RT. Unbound protein was removed by
washingwithPBS-T, biotinylateddetectingmAbwasadded
(0.5–1g/ml in PBS, 50l/well) and plates were incubated
for 1h at RT. They were then washed three times, prior
to the addition of 50l/well of streptavidin–horseradish
peroxidase (AbD Serotec) diluted 1:500 in PBS-T and incu-
bation for 1h at RT. After washing three times in PBS-T,
peroxidase activity was developed by adding 75l/well
of Ready-to-use tetramethylbenzidine (TMB) substrate
(Sigma) for 10–15min at RT. The reaction was stopped
by the addition of 75l/well of 0.5M H2SO4. Absorbance
was read at 450nm in a SpectraMax 250 microplate spec-
trophotometer system (Molecular Devices).
Dot blots were performed by dotting recombinant
cytokines or control samples onto Hybond C+ nitrocellu-
lose membrane (GE Healthcare Life Sciences) and allowed
to air-dry. Blots were then incubated in blocking solution
(5% skimmed milk powder in PBS) overnight, at RT. After
washing three times inPBS-T, theywere incubatedwith the
anti-chIL-12p40 mAbs, diluted 1:10 in blocking buffer, for
1h at RT. Primary antibody was removed by washing three
times in PBS-T and blots were then incubated with rab-
bit anti-mouse immunoglobulin conjugated to horseradish
peroxidase (DAKO, Glostrup, Denmark) diluted 1:1000 in
PBS, for 1h at RT. After a further ﬁve washes in PBS-T,
detection was carried out using enhanced chemilumines-
cence (ECL) (GE Healthcare Life Sciences), according to the
manufacturer’s instructions.
2.4. Isolation of bone marrow-derived macrophages and
stimulation to produce IL-12
Femurs of 5- to 6-week-old Rhode Island Red chickens
were removed post-mortem and isolated from the sur-
rounding muscle tissue using sterile instruments. Both
ends of the bone were cut off and the marrow ﬂushed
out with RPMI 1640 medium, using a 21G needle and
syringe. Clumps of marrow were disaggregated by pipet-
ting and large debris excluded by passing the suspension
through a 100m cell strainer. The cell suspension was
Author's personal copy
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washed in RPMI 1640, resuspended at 5×106 cells/ml
in complete media (RPMI 1640 containing 5% chicken
serum (Invitrogen), 1% l-glutamine, 1U/ml penicillin and
1g/ml streptomycin) supplementedwith rchGM-CSF (ex-
COS, 1:100; Avery et al., 2004), plated out in 24-well plates
and incubated for 7 days at 41 ◦C, 5% CO2. The adherent
monolayer of cells were re-fed every 2–3 days, by care-
fully removing non-adherent cells and spent media, and
replacing with fresh complete media containing rchGM-
CSF. On day 7 of culture, cells were stimulated with a
variety of compounds to induce IL-12 expression: ConA
(Sigma) (1g/ml); LPS (E. coli serotype 055:B5 (Sigma),
4g/ml); CpG DNA (pCI-neo plasmid DNA (Promega),
10g/ml); soluble CD40 ligand (CD40L or CD154) fusion
protein (3g/ml) (Tregaskes et al., 2005); polyI:C (Sigma)
(30g/ml). All were used in the presence or absence of
rchIFN- (ex-COS, 1:200; Lawson et al., 2001). Cells were
stimulated for 4.5h and 18h, at which point supernatants
were collected for assaying by capture ELISA and cells har-
vested for RNA isolation using an RNeasymini kit (QIAGEN,
Crawley, UK).
2.5. Real-time quantitative RT-PCR
IL-12p35 and IL-12p40 mRNA levels were quantiﬁed
by TaqMan qRT-PCR, using a well-described method
(Avery et al., 2004; Eldaghayes et al., 2006; Rothwell et al.,
2004). Primers and probes for IL-12p35, p40 and 28S RNA-
speciﬁc ampliﬁcation have been described previously but
for clarity their sequences are as follows: IL-12p35 forward
primer, TGGCCGCTGCAAACG; reverse, ACCTCTTCAAGGGT-
GCACTCA; probe, CCAGCGTCCTCTGCTTCTGCACCTT.
IL-12p40 forward primer, TGGGCAAATGATACGGT-
CAA; reverse, CAGAGTAGTTCTTTGCCTCACATTTT; probe,
CTGAAAAGCTATAAAGAGCCAAGCAAGACGTTCT. 28S
forward primer, GGCGAAGCCAGAGGAAACT; reverse,
GACGACCGATTTGCACGTC; probe, AGGACCGCTACGGAC-
CTCCACCA. Probes were all labelled with the ﬂuorescent
reporter dye FAM at the 5′ end and with the quencher
TAMRA at the 3′ end. The RT-PCR was performed using
the TaqMan Fast Universal PCR master mix and one-
step qRT-PCR master mix reagents (Applied Biosystems,
Warrington, UK). Ampliﬁcation and detection of speciﬁc
products were performed using the 7500 Fast Real-Time
PCR System (Applied Biosystems) with the following cycle
proﬁle: one cycle of 48 ◦C for 30min and 95 ◦C for 20 s,
and 40 cycles of 95 ◦C for 3 s and 60 ◦C for 30 s. Results are
expressed as 40-Ct, after normalising each sample using
the Ct value for the 28S rRNA product for the same sample,
as described previously (Avery et al., 2004; Eldaghayes
et al., 2006; Rothwell et al., 2004).
2.6. Immunocytochemistry
Rhode Island Red chickenswere infected at threeweeks
of age with 101.7 EID50 of the virulent infectious bursal
disease virus (IBDV) strain F52/70 (Bygrave and Faragher,
1970) by the intranasal route in a total volume of 100l
(Eldaghayes et al., 2006). Bursal tissue from 5 infected
and 3 age-matched uninfected control birds at 4 days
post-infection was snap-frozen in OCT (Sakura Finetek,
Thatcham, UK). Frozen sections (6–8m) of the bursa
of Fabricius were cut using a cryostat, placed onto glass
slides, ﬁxed in acetone for 10min and air-dried. Stain-
ing was carried out using a Vectastain® ABC anti-mouse
IgG HRP staining kit (Vector Laboratories, Burlingame, CA,
USA) following the manufacturer’s instructions, using the
anti-chIL-12p40 mAbs (diluted 1:10 in PBSa, 1% bovine
serum albumin, 0.1% sodium azide) (or appropriate isotype
control mAbs) as the primary antibody. Staining was visu-
alised by incubation with peroxidase substrate solution
(Vector® NovaREDTM) and subsequent counter-staining
with haematoxylin, to produce red staining for the target
cells and blue staining for the background.
3. Results and discussion
This paper describes the production and characterisa-
tion of murine anti-chIL-12p40 mAbs, following successful
DNA immunisation of mice. Of the ﬁve mAbs generated,
two have been used to successfully develop an IL-12-
speciﬁc capture ELISA, as described below.
Following threeDNA immunisations, twooutof sixmice
showed good antibody responses, as measured by indi-
rect ELISA, and one was used for a fusion. Fusion plates
were also screened by indirect ELISA, and ﬁve IL-12p40-
speciﬁc antibody-secreting hybridomas were selected for
cloning, expansionandcharacterisation. TwomAbs (AV114
and AV140) were IgM and were not characterised further.
The three remaining mAbs (AV134, AV135 and AV136)
were IgG1 isotype, and all recognise rchIL-12p40 and rchIL-
12p70 inboth indirect ELISA (Fig. 1A) anddot blots (Fig. 1B).
Fig. 1B shows that the mAbs are speciﬁc for chIL-12 and do
not cross-react with recombinant mammalian (human or
bovine) IL-12, nor with supernatant from COS cells trans-
fected with pCI-neo alone, or pCI-neo expressing chIFN-.
The three mAbs only bind to IL-12p40 in its native form,
but do not recognise denatured antigen (Fig. 1B).
Various combinations of the three IgG1 mAbs, at dif-
ferent dilutions, were used to develop an IL-12 capture
ELISA. Since the three mAbs were of the same isotype,
unconjugated mAbs were used as capture Abs, whilst
biotinylated mAbs were used as the detecting mAbs. All
three mAbs worked in all possible combinations, with the
optimal pair being AV136 (capture mAb, at 2g/ml) and
biotinylated-AV134 (detecting mAb, at 0.5g/ml), result-
ing in the greatest sensitivity. The capture ELISA readily
detected recombinant chIL-12p40 and chIL-12p70 derived
from COS cells (Fig. 2), in a dose-dependent manner, and
was then used to identify “native” IL-12 expressed by stim-
ulatedprimarymacrophages in vitro (Fig. 3A). Bonemarrow
cellswere cultured in vitro for 7 d in the presence of rchGM-
CSF to generate primary macrophages, which were then
stimulated with a variety of compounds known to induce
IL-12 production in mammals, including TLR agonists such
as LPS, CpG DNA, and polyI:C and host-related stimuli such
as CD40L, with or without IFN- priming. Cells and super-
natants were harvested at 4.5 and 18h post-stimulation
(hps). RNA was isolated from the cells for subsequent anal-
ysis by qRT-PCR (Fig. 3B) and supernatants were assayed
for IL-12 using the capture ELISA (Fig. 3A).
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Fig. 1. Speciﬁcity of mouse anti-chicken IL-12p40 mAbs AV134, AV135 and AV136 demonstrated by (A) indirect ELISA against rchIL-12p40 and rchIL-
12p70; rchIFN- was used as a negative control. (B) Dot blots showing speciﬁcity of the three mAbs against various sources of recombinant IL-12 – 1:
pCI-neo (ex-COS); 2: rchIFN- (ex-COS); 3: rchIL-12p40 (ex-COS); 4: rchIL-12p70 (ex-COS); 5: rhuIL-12 (100g/ml); 6: rbovIL-12 (ex-COS), and that the
three mAbs recognise antigen in the native form; 7: rchIL-12p40 (ex-COS) in the native form; 8: rchIL-12p40 (ex-COS) heat-denatured; 9: pCI-neo (ex-COS)
in the native form; 10: pCI-neo (ex-COS) heat-denatured.
Unsurprisingly, no IL-12 was detected in the cul-
ture supernatants harvested at 4.5 hps. However, IL-12
was detected in the supernatants harvested 18 hps from
macrophages stimulatedwith LPS and IFN-, and to a lesser
extent in those stimulated with LPS and CD40L (Fig. 3A).
Analysis of IL-12 mRNA expression by qRT-PCR (Fig. 3B)
showed signiﬁcant up-regulation of IL-12p35 and IL-12p40
in the same samples at 4.5 hps. IL-12p40 mRNA was also
Fig. 2. Capture ELISA using mouse anti-chicken IL-12p40 mAb AV136 as the capture Ab (at 2g/ml) and biotinylated-anti-chIL-12p40 mAb AV134 (at
0.5g/ml) as the detecting Ab. Capture ELISA detects both rchIL-12p40 (ex-COS) (black bars) and rchIL-12p70 (ex-COS) (grey bars) at different dilutions.
Author's personal copy
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Fig. 3. Expression of IL-12 following stimulation of primary bone marrow-derived macrophages after 7 days of culture in the presence of rchGM-CSF.
(A) IL-12 protein expression detected in the culture supernatant by capture ELISA (using mAbs AV136 and AV134) at 4.5 and 18h post-stimulation
(hps) (grey and black bars, respectively). (B) IL-12p35 (grey bars) and IL-12p40 (black bars) mRNA expression detected by qRT-PCR at 4.5 hps. 1: media;
2: ConA (1g/ml); 3: LPS (E. coli serotype 055:B5, 4g/ml); 4: CpG DNA (pCI-neo, 10g/ml); 5: soluble chCD154 fusion protein (3g/ml); 6: polyI:C
(30g/ml); 7: LPS (4g/ml) + recombinant chIFN- (ex-COS, 1:200); 8: CD154 (3g/ml) + rchIFN- (1:200); 9: polyI:C (30g/ml) + rchIFN- (1:200); 10:
CD154 (3g/ml) + LPS (4g/ml); 11: CD154 (3g/ml) +polyI:C (30g/ml); 12: polyI:C (30g/ml) + LPS (4g/ml). qRT-PCR results are expressed as mean
corrected 40-Ct values± SE. The data shown are representative of three independent experiments.
up-regulated in macrophages stimulated with LPS alone or
CpG DNA when compared to unstimulated macrophages,
and although IL-12p35 was also detected in those samples,
it was not as highly expressed as in the LPS+ IFN-- and
LPS+CD40L-stimulated samples. IL-12p35 mRNA was not
detected in cells cultured in media alone, in the presence
of CD154 or polyI:C alone, or in the presence of CD154 and
rchIFN- or polyI:C. By 18 hps, IL-12p40 mRNA expression
was no longer signiﬁcantly up-regulated, whilst IL-12p35
was still up-regulated in some cells (data not shown). Bio-
logically active IL-12 (IL-12p70) can only be produced in
cells that co-express both p35 and p40 subunits (Gubler
et al., 1991), and in mammals IL-12p35 is ubiquitously and
constitutively expressed, so it is the more tightly regu-
latedand restrictedexpressionof IL-12p40 that determines
a cell’s ability to produce functional IL-12 (Gately et al.,
1998). In contrast, in the chicken, IL-12p40 is ubiquitously
expressed in a wide variety of tissues (Balu and Kaiser,
2003), whilst expression of IL-12p35 is more tightly con-
trolled (Balu, 2005; Degen et al., 2004), thus determining
the production of the functional p70 molecule. The cap-
ture ELISA data (Fig. 3A), in concert with the qRT-PCR data
(Fig. 3B), indicates that it is both the expression of p35
and the abundance of p40 that determines the amount
of IL-12p70 produced. We have shown that, as in mam-
mals, effective induction of chIL-12 in vitro requires at
least two different signals (Snijders et al., 1998), speciﬁ-
callybacterial LPS (activating theTLR4pathway) alongwith
an ‘endogenous’ signal such as engagement of the CD40-
CD40L signalling pathway or co-stimulation via IFN-.
Using qRT-PCR, we had previously shown that IL-12p35
mRNA expression is up-regulated in the bursa two to four
days post-infection (dpi) with virulent IBDV F52/70, whilst
IL-12p40 is constitutively expressed in bothuninfected and
infected birds (Eldaghayes et al., 2006). Bursal sections (4
dpi) from the same IBDV-infection experiment (Eldaghayes
et al., 2006) were stained with the anti-chIL-12p40 mAbs
described herein, to investigate their utility in immuno-
cytochemistry. Clear positive staining of IL-12-producing
cells (using both mAbs, AV135 and AV136) was seen in the
bursae of infected birds (Fig. 4B and D) when compared
to bursal sections from age-matched control birds (Fig. 4A
and C). Positively stained cells are mainly seen in the cor-
tex of the bursa and at the cortico-medullary junction,with
some IL-12-positive cells in the medulla, as well as in the
interfollicular tissue. IBDV infection results in gross bur-
Author's personal copy
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Fig. 4. Intracellular staining of cryosections of the bursa of Fabricius with
anti-chIL12mAbs by immunocytochemistry. (A, C and E) Sections of bursa
from uninfected birds stained with anti-chIL-12p40 mAbs AV135, AV136
or an isotype control mAb, respectively. (B, D and F) Bursal sections from
birds infected with the virulent infectious bursal disease virus strain
F52/70 at 4 days post-infection, stained with AV135, AV136 or an iso-
type control mAb, respectively. Black arrows indicate selected positively
stained (red) cells. Sections were counterstained with haematoxylin.
sal damage, caused by signiﬁcant B lymphocyte depletion
within the follicles; there is an inﬂux of T cells, and migra-
tion of some mononuclear phagocytes into the damaged
bursal follicles (Vervelde and Davison, 1997), which may
be responsible for the production of IL-12 within the dam-
aged bursa. Staining with the isotype control mAbs did not
show any positive staining (Fig. 4E and F) in sections from
either the uninfected or the infected birds.
We presume these mAbs are recognising IL-12p70, as
IL-12p40 is constitutively expressed in the chicken, yet
no staining was seen in the bursae of uninfected control
birds. The observed lack of binding in uninfected bursal
tissues may reﬂect a defect in full protein translation and
production in uninfected animals, perhaps indicating that
the bioactive protein is only produced in response to IBDV
infection. However, in mammals IL-23 is a heterodimer of
IL-23p19 and IL-12p40. Although chIL-23p19 has yet to be
described, we cannot rule out that these mAbs could be
recognising chIL-23.
In summary, the data presented here show that the
mAbs raised against chicken IL-12p40 can be used to detect
natural chicken IL-12 in a capture ELISA, allowing us for
the ﬁrst time to speciﬁcally measure this pivotal Th1-
driving cytokine at the protein level in the chicken. The
mAbs have been successfully used to detect IL-12-positive
cells in frozen sections using immunocytochemistry, and
may, with further optimisation, be suitable for use in ﬂow
cytometry and ELISpot assays. Further characterisation is
required to ascertain whether the mAbs are capable of
neutralising the bioactivity of chIL-12 or if they work in
Western blot.
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